Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study-Reference-Cited by-同舟云学术

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Published:2014-10-20 Issue:5 Volume:115 Page:736-743
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Sourbeer Katharine N.¹²,Howard Lauren E.¹²,Andriole Gerald L.³,Moreira Daniel M.⁴,Castro-Santamaria Ramiro⁵,Freedland Stephen J.¹²⁶,Vidal Adriana C.¹²⁶⁷

Affiliation:

1. Urology Section; Veterans Affairs Medical Center; Durham NC USA

2. Division of Urology; Department of Surgery; Duke Prostate Center; Duke University School of Medicine; Durham NC USA

3. Division of Urologic Surgery; Washington University School of Medicine; St. Louis MO USA

4. The Arthur Smith Institute for Urology; North Shore Long Island Jewish Health System; New Hyde Park NY USA

5. Oncology Research & Development; GlaxoSmithKline; Philadelphia PA USA

6. Cancer Detection, Prevention and Control Program; Duke University; Durham NC USA

7. Division of Clinical and Epidemiologic Research; Department of Obstetrics and Gynecology; Duke University; Durham NC USA

Funder

NIH

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12843/fullpdf

Reference37 articles.

1. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity;Alberti;Circulation,2009

2. Metabolic syndrome: definitions and controversies;Kassi;BMC Med,2011

3. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey;Ford;JAMA,2002

4. Global cancer statistics;Jemal;CA Cancer J Clin,2011

5. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significantly reduced incidence and improved survival from prostate cancer over 25 years;BMC Public Health;2023-12-21

2. Statins may increase the risk of being diagnosed with prostate cancer;Minerva Urology and Nephrology;2023-10

3. A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov;Medicina;2023-06-07

4. Role of Metabolism and Metabolic Pathways in Prostate Cancer;Metabolites;2023-01-25

5. Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram;Metabolites;2023-01-09